FDA WARNING_LETTER - The-Vape-Place LLC - March 04, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
On March 4, 2019, the FDA issued a Warning Letter to The-Vape-Place LLC, specifically addressing Gordon Tinsley and Angie Tinsley, following a review of their website, https://the-vape-place.com. The FDA determined that numerous e-liquid products manufactured, advertised, and sold by The-Vape-Place LLC are misbranded tobacco products.
The core violation is the failure to include the required nicotine warning statement, "WARNING: This product contains nicotine. Nicotine is an addictive chemical," on the labeling and/or advertising for 50 specific e-liquid products listed in the letter. This violates 21 C.F.R. § 1143.3(a) and/or 21 C.F.R. § 1143.3(b). Consequently, these products are misbranded under sections 903(a)(7)(B), 903(a)(1), and/or 903(a)(7)(A) of the FD&C Act (21 U.S.C. § 387c(a)(7)(B), 387c(a)(1), and/or 387c(a)(7)(A)).
The FDA requires immediate corrective action, including discontinuing the violative labeling, advertising, sale, and distribution of these products
ID · 8ae8522d-e5bf-44bd-8310-680e44ba3900
Full citation text and observation details available on the Dashboard.